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ABSTRACT
The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in Hungary has been increasing
and is now close to 20% among invasive isolates of S. aureus. In order to understand the evolution of
MRSA in Hungary, two collections of isolates were studied: 22 representatives of a collection of 238
MRSA isolates recovered between 1994 and 1998, and a collection of 299 MRSA isolates recovered
between 2001 and 2004. The isolates were ﬁrst characterised by pulsed-ﬁeld gel electrophoresis (PFGE)
and were distributed into 19 different PFGE patterns. Representatives of each pattern were further
characterised by spa typing, multilocus sequence typing (MLST) and staphylococcal cassette chromo-
some mec (SCCmec) typing. The Hungarian clone that was predominant in 1994–1998 (PFGE E, ST239-
III) had almost disappeared in 2003–2004, being replaced by the Southern German clone (PFGE B,
ST228-I) and the New York ⁄ Japan epidemic clone (PFGE A, ST5-II), which represented c. 85% of the
2001–2004 isolates. Thus, this study describes, for the ﬁrst time, the co-dominance and extensive spread
of the New York ⁄ Japan clone in a European country.
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INTRODUCTION
During the past two decades, methicillin-resistant
Staphylococcus aureus (MRSA) has become the
most prevalent and important nosocomial patho-
gen, causing serious infections such as skin
abscesses and wound infections, osteomyelitis,
endocarditis, pneumonia, meningitis, bacteraemia
and toxic shock syndrome [1]. More recently,
MRSA infections have been reported in the
community among patients with and without
traditional risk-factors for MRSA infection. These
latter infections are associated predominantly
with skin and soft-tissue abscesses and cellulitis
[2].
In Europe, the prevalence of MRSA varies
widely among nations and is consistently higher
in southern countries, e.g., Portugal, Spain, Italy,
France and Greece, which report a prevalence of
>30%, as compared with <2% in Scandinavian
countries, Switzerland and The Netherlands
(http://www.earss.rivm.nl). In central and
eastern Europe, the prevalence of MRSA has been
estimated at c. 15% in Austria, the Czech Repub-
lic and Slovenia, between 20% and 37% in
Hungary, Slovakia, Poland, Bulgaria and Croatia,
and >60% in Romania (http://www.earss.
rivm.nl) [3].
Epidemiological studies using molecular typing
methods have indicated that the massive
geographical spread of MRSA results from the
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dissemination of a few highly epidemic clones.
These major epidemic clones belong to sequence
type (ST) 5 (SCCmecII—New York ⁄ Japan, and
SCCmecIV—Pediatric), ST239 (SCCmecIII ⁄ IIIA—
Brazilian), ST247 (SCCmecIA—Iberian), ST22
(SCCmecIV—EMRSA-15), ST36 (SCCmecII—-
EMRSA-16) and ST45 (SCCmecIV—Berlin) [4–6].
Another epidemic MRSA clone, sharing ST239
with the Brazilian clone, was described for the
ﬁrst time in Hungary, and was reported to be
widely dispersed in Hungarian hospitals between
1993 and 1998 [7,8]. Further studies reported the
local predominance of this clone in other regions
of the world, namely Taiwan and China [9], and
more recently in India [10], Poland [11] and
Norway [12]. Norway has one of the lowest
rates of MRSA in Europe, which indicates the
high capacity for dissemination of this particular
clone.
Besides the limited number of MRSA clones
circulating in Europe, the phenomenon of clonal
replacement has been observed; i.e., clones that
were disseminated widely during the beginning
of the last decade have become less common and
have been replaced by other epidemic clones. In
Portuguese hospitals, the prevalent Portuguese
clone (ST239-III variant) in the mid-1980s was
replaced by the Iberian clone (ST247-IA) in
1992–1993, and later, by the Brazilian clone
(ST239-III ⁄ IIIA) [5]. Another example of clone
replacement was observed in German hospitals
between 1994 and 2002. The Northern German
(ST247-I) and the Hannover (ST254-IV) clones,
which were prevalent at the beginning of the
1990s, were replaced in 2000 by the Berlin (ST45-
IV), the Southern German and the Barnim (ST22-
IV) clones, and 1 year later by the Rhine-Hesse
(ST5-II) MRSA epidemic clone [13]. Also, in the
Czech Republic, Melter et al. [14] reported the
arrival of the epidemic EMRSA-15 (ST22-IV)
clone, replacing the previously prevalent clones
in the country, i.e., the Brazilian or ST239-related
clones and the Iberian (ST247-IA) clone.
The incidence of MRSA in Hungary is currently
c. 20% among invasive isolates of S. aureus
(http://www.earss.rivm.nl). However, since the
late 1990s, there have been no molecular data
available from Hungary. Therefore, the aims of
the present study were, ﬁrst, to provide an update
of the MRSA clonal types circulating in Hungary
between 2001 and 2004, and second, to trace the
temporal evolution of the epidemic clones in
Hungary during the last decade.
MATERIALS AND METHODS
Bacteria
The study investigated two collections of isolates: (i) 299
isolates selected from among 3539 MRSA isolates, recovered
between 2001 and 2004 from different provincial hospitals
located in 18 of the 19 Hungarian counties (Fig. 1), sent to the
Hungarian National Center for Epidemiology as part of
routine MRSA surveillance—the 299 isolates were all single
patient invasive isolates (from blood cultures or cerebrospinal
ﬂuid), with 15 isolates from 2001, 48 isolates from 2002, 103
isolates from 2003, and 133 isolates from 2004; and (ii) 22 clinical
MRSA isolates selected from among 238 MRSA isolates recov-
ered between 1994 and 1998 in six Hungarian counties (Fig. 1)
[8]—these 22 isolates represented all of the pulsed-ﬁeld gel
electrophoresis (PFGE) proﬁles described by Oliveira et al. [8],
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Fig. 1. Comparison of the geographical distribution of the major methicillin-resistant Staphylococcus aureus clones in
Hungary during 1994–1998 and 2001–2004. The Hungarian clone (ST239-III) is represented by circles, the Southern German
clone (ST228-I) by triangles, and the New York ⁄ Japan clone (ST5-II) by squares. The counties studied in each period are
highlighted in grey.
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and were included in the present study to enable a more
detailed characterisation in order to trace the evolution of the
clonal types circulating in Hungary between 1994 and 2004.
Antimicrobial susceptibility testing
Susceptibility to oxacillin, vancomycin, ciproﬂoxacin, erythromycin,
clindamycin, gentamicin, trimethoprim–sulphamethoxazole,
tetracycline, rifampicin, teicoplanin, quinupristin–dalfopristin
and linezolid was tested by the disk-diffusion method
according to CLSI guidelines [15]. Antimicrobial susceptibility
testing for oxacillin and vancomycin was also performed using
Etests (AB Biodisk, Solna, Sweden) according to the
manufacturer’s instructions. S. aureus ATCC 25923 was used
as a quality control strain for antimicrobial susceptibility
testing.
Phage typing
The isolates recovered between 2001 and 2004 were typed
using the international basic set of phages for S. aureus isolates
of human origin, and a set of ten phages selected by
Richardson et al. [16] that were developed in certain countries
in response to local problems in typing MRSA strains. All
phages were used at 100· the routine test dilution.
PFGE
PFGE was performed for all isolates as described by Chung
et al. [17]. In brief, genomic DNA samples immobilised in
agarose were digested overnight with SmaI (New England
BioLabs, Beverly, MA, USA), followed by resolution of the
restriction fragments in a CHEF-DRIII contour-clamped homo-
geneous electric ﬁeld apparatus (Bio-Rad, Hemel Hempstead,
UK). PFGE patterns were analysed visually and interpreted
using the criteria of McDougal et al. [18], and were also
analysed using BioNumerics v.4.0 (Applied Maths, Sint-Mar-
tens-Latem, Belgium). Concatamerised phage k DNA (New
England BioLabs) and a SmaI genomic digest of S. aureus
NCTC 8325 were used as internal markers to normalise the
gels. Percentage similarities were determined from a dendro-
gram that was constructed using the unweighted pair group
with arithmetic averages (UPGMA) method and the Dice coef-
ﬁcient, with band position tolerance and optimisation set at
1%. According to Carric¸o et al. [19], and after reviewing the
epidemiological data associated with each of the clusters, a
similarity coefﬁcient of 80% was used to deﬁne the PFGE type
clusters.
spa typing
Analysis of polymorphism in the X region of the protein A
gene (spa) was performed as described previously [20] for at
least one representative of each PFGE type (n = 40). The spa
types were determined by assignment according to the
Ridom web server (http://www.ridom.de/spaserver/), using
Ridom StaphType v.1.4.10 software (Ridom GmbH, Wurz-
burg, Germany) and the eGenomics web server (http://
tools.egenomics.com/). As observed previously [20,21], spa
types with similar repeat proﬁles were grouped together in
spa lineages, which were identiﬁed in the present study by
numbers.
Multilocus sequence typing (MLST)
MLST was performed on at least one representative of each
PFGE pattern (n = 49) by PCR ampliﬁcation of internal
fragments of seven housekeeping genes as described by
Enright et al. [22], except that primer arcCF2 (5¢-CCTTTATTT-
GATTCACCAGCG) was used [23], or according to van
Leeuwen et al. [24]. The allelic proﬁle, and hence the ST, of
each isolate was identiﬁed using the MLST database (http://
www.mlst.net).
SCCmec and ccrAB typing
The staphylococcal cassette chromosome mec (SCCmec) type
was determined for at least one representative of each PFGE
pattern ⁄ spa lineage (n = 66) using the multiplex PCR strategy
developed by Oliveira and de Lencastre [25], which assembles
a speciﬁc ampliﬁcation proﬁle for each cassette type. A ccrAB
(cassette chromosome recombinase)-speciﬁc PCR [26] was
performed to conﬁrm the presence of SCCmec type IV, and
also when a non-conclusive result was obtained using
the multiplex strategy. Ampliﬁcation of ccrB [27] was also
performed for one isolate that was not typeable using the
above approaches.
Panton–Valentine leukocidin (PVL) gene analysis
The presence of the PVL lukS ⁄ lukF genes was investigated by
PCR [28] for representatives of each PFGE pattern.
RESULTS
Antibiotic proﬁles and phage typing
The 321 isolates were assigned to 12 antibio-
types (Table 1). All isolates were resistant to
oxacillin, and high proportions were resistant to
erythromycin (95.6%), ciproﬂoxacin (95.3%),
clindamycin (87.9%) and gentamicin (58.9%).
None of the isolates was resistant to linezolid,
teicoplanin, quinupristin–dalfopristin or vanco-
mycin.
Among the 299 isolates collected between 2001
and 2004, 193 (64.5%) were typeable with both
sets of phages: 154 belonged to phage group III,
13 to group 83A, ten to group I, nine to group 95,
and seven to group 80. The remaining 106
isolates, which could not be assigned to a deﬁned
group, included 58 non-typeable isolates and 48
belonging to mixed groups. These 48 isolates
included 22 isolates from mixed groups III + 95,
nine isolates from groups III + I, six isolates from
groups III + II, and ﬁve isolates from groups
III + 94 ⁄ 96. Mixed groups I + 83A, I + 94 ⁄ 96 and
II + 83A each contained a single isolate, and the
remaining three isolates belonged to groups
83A + 94 ⁄ 96.
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Macrorestriction analysis
All 321 MRSA isolates were studied by PFGE.
Although the isolates were distributed into 19
PFGE patterns (types A–C, E–L, P–T, V, X and Z)
differing by six or more bands, two major clonal
groups could be distinguished: pattern B, account-
ing for 141 (44%) of the isolates, and pattern A,
accounting for 113 (35.2%) isolates. With the
exception of pattern E (n = 13, 4.5%), all remaining
cloneswere represented by<4%of the isolates, and
were considered to be minor clones (Table 1).
spa typing, MLST and SCCmec typing
Representatives of the 19 PFGE patterns were
characterised further by spa typing (n = 40),
MLST (n = 49) and SCCmec type (n = 66)
(Table 1). According to spa typing, the isolates
were assigned to seven spa lineages. MLST iden-
tiﬁed 11 different sequence types (ST5, ST228,
ST239, ST36, ST254, ST247, ST8, ST1, ST45, ST22
and ST875), which belonged to seven clonal
complexes (CC5, CC8, CC1, CC30, CC45, CC22
and CC12).
All four of the typical SCCmec types I–IV, as
well as variants IA, IIIA and IVA, were detected
among the isolates investigated. One isolate,
belonging to CC12, was mecA-positive, but was
not typeable by the PCR multiplex strategy [26],
or by ccrAB [27] and ccrB [28] typing. In the two
predominant clonal complexes, CC5 appeared to
be associated with both SCCmecI and SCCmecII,
while SCCmecIII and SCCmecIIIA were detected
only in CC8, in association with ST239.
Although PFGE patterns A and B, which
included most (n = 254) of the isolates, were
assigned to a speciﬁc spa type, i.e., spa type
t002 ⁄ 2 or spa type t041 ⁄ 388 (RIDOM ⁄ eGenomics
nomenclature), respectively, they shared the same
spa motif r20r17r12r17r16 (eGenomics nomen-
clature: DMGMK) and were both associated with
spa lineage 1. Lineage 2, motif r16r02r25r17r24
(eGenomics nomenclature: KAOMQ), included
nine PFGE patterns that, with the exception of
pattern L, all belonged to ST239-SCCmec type III
(or IIIA).
Of the 11 STs identiﬁed, two predominated
(>113 isolates each) and belonged to CC5: (i) ST5,
associated with PFGE patterns A and J, and with
SCCmecII; and (ii) ST228, a double-locus variant of
ST5 in the tpi and yqiL alleles, corresponding to
PFGE pattern B and SCCmecI.
PVL screening
Representatives (n = 65) of each PFGE pattern
were selected randomly and tested for the pres-
ence of the PVL determinant. None of the isolates
tested positive for the genes encoding PVL.
Temporal and geographical clonal distribution
The evolution of MRSA clones in Hungarian
hospitals between 1994 and 2004 is summarised in
Fig. 2. Previous data [8] and the results obtained
for the 22 representative isolates by spa typing,
MLST and SCCmec typing showed that 99% of the
isolates (i.e., all except two isolates) from 1994–
1996 belonged to ST239-III. Several PFGE patterns
were associated with the ST239-III isolates, but the
Hungarian clone (PFGE E) was clearly predomi-
nant (74%). Over time, the prevalence of ST239-III
clones, including the Hungarian clone, decreased
progressively to a minimum of <0.5% in 2003–
2004. In parallel, two other well-represented
clones emerged in Hungary: (i) PFGE B–ST228-I
(the Southern German clone) was introduced in
1997–1998, represented by 28% of the isolates;
and (ii) PFGE A–ST5-II (the New York ⁄ Japan
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clone) emerged in 2001–2002, with a prevalence of
30%. Over time, the prevalence of both clones
increased, reaching 50% and 40%, respectively, in
2003–2004, at which time they became the two
most prevalent clones isolated in Hungary. The
two isolates recovered in 1994–1996 that did not
share ST239 were found to belong to the
Hannover clone (PFGE F–ST254-IV). This clone,
absent during 1997–1998, re-emerged during
2001–2002 (6%), but remained at a relatively low
prevalence (1%) during the following years.
The MRSA isolates from 1994–1998 were recov-
ered from six of the 19 Hungarian counties, while
the prevalent Hungarian clone ST239-III was
found in ﬁve different counties throughout the
country (Fig. 1). Despite the fact that the county in
which the capital was located was over-repre-
sented among the 2001–2004 isolates, all except
one of the remaining counties were represented in
this collection (Fig. 1). During this second study
period, the Hungarian clone (or ST239-related
clones) was still present in four counties through-
out Hungary, three of which were included in the
1994–1998 study, as well as in an additional
southern county. The Southern German clone
ST228-I, which was restricted to one county until
1999, was isolated subsequently in nine additional
counties throughout Hungary. Moreover, the
New York ⁄ Japan clone ST5-II, present in Hungary
only since 2001, was widespread throughout 11
counties. The rapid dissemination of these clones
might be linked to the transfer of Hungarian
patients from hospital to hospital, and hence from
county to county.
DISCUSSION
Few surveillance studies have described the
evolution of MRSA in central and eastern Europe.
Although there was a gap in the present study
between 1999 and 2000, during which MRSA
isolates from Hungary were not obtained, this
report describes the evolution of the clonal types
circulating in Hungary over the last decade.
The predominance of a single clone in Hun-
garian hospitals between 1993 and 1994 was
reported by de Lencastre et al. [7]. This Hungarian
clone, characterised by ST239-III, was related
closely to the epidemic Brazilian clone, which is
dispersed widely in Europe, South America and
Asia [5]. Oliveira et al. [8] used a combination of
spa typing and PFGE typing to reveal a signiﬁcant
decrease in the prevalence of the Hungarian
clone, from c. 74% in 1994–1996 to 42% in 1997–
1998. Although the Hungarian clone has also been
described in Poland [11] and Norway [12], the
present results show that it is currently almost
non-existent in Hungary. Two other clones, both
belonging to CC5, i.e., the Southern German
(ST228-I) and the New York ⁄ Japan (ST5-II) clones,
are now the predominant clones in Hungarian
hospitals.
The Southern German clone was ﬁrst described
in the southern area of Germany in 1992, and
spread throughout Germany during 1995–1996
[29]. About 1 year later, this clone was detected in
Budapest, the Hungarian capital, with a preva-
lence of 28%, and then spread rapidly throughout
Hungary, becoming the prevalent clone in 2003–
2004. ST228-I has also been reported to be the
predominant clone (86% of MRSA isolates) in a
hospital in Slovenia [30]. In Croatia, which also
borders Hungary, Budimir et al. [31] reported that
ST111-I, a single-locus variant of ST228 with the
same SCCmec type, occurred at a prevalence of
52% in bloodstream isolates. Moreover, other
minor clones associated with ST228-I have been
reported in Italy [32], Denmark [33], Belgium [34]
and Switzerland [35] (http://www.mlst.net),
showing that clone ST228-I, or related STs, are
relatively common in Europe.
After being isolated in northern European
countries [5], ST5 was detected in Hungary soon
after its double-locus variant, ST228. ST228 seems
to have evolved from ST5 [36]. However, the
appearance of these two clones in Hungary
probably represents independent events, since
ST228 was the ﬁrst to be detected (Fig. 2). ST5
appeared almost simultaneously in 11 counties,
whereas ST228 was ﬁrst isolated in the restricted
area of Budapest, and only spread later through-
out the country. Interestingly, to our knowledge,
the New York ⁄ Japan clone has never been
described in countries bordering Hungary, and
was therefore probably imported from countries
in which it is highly prevalent, i.e., the USA,
Japan, Korea and Mexico [37–39]. Nevertheless,
clone ST5-II has been reported recently in some
Belgium hospitals, as was the ST45-IV clone,
which was predominant among 251 isolates
recovered from 95 hospitals during 2003 [40].
ST45-IV was also isolated in Hungarian hospitals,
but with a very low prevalence (three isolates).
Other epidemic clones have been described in
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central Europe, e.g., EMRSA-15 (ST22-IV), which
has been detected in hospitals throughout all
regions of the Czech Republic, replacing both the
Brazilian (ST239) and related clones, and the
Iberian clone (ST247) [14]. Interestingly, one of
the minor clones described in Hungary, PFGE
pattern V (Table 1), belonged to ST22-IV and was
represented by two isolates from a single county.
Thus, ST5 and related clones, such as ST228 and
ST111, as well as the non-multiresistant EMRSA-
15 (ST22) clone, are becoming the major clones
circulating in eastern European countries, in
addition to the Iberian and the Brazilian or
ST239-related clones.
Concerning the 2001–2004 MRSA collection,
with the exception of phage groups 80 and 83A,
which belonged only to PFGE pattern A, the other
phage groups (I and III) included more than one
PFGE pattern. In the two major PFGE patterns, A
and B, most isolates belonged to phage group III.
Phage typing is still used to characterise S. aureus
[41], but this collection showed low typeability,
with 35.4% of the isolates not being assigned to any
group (i.e., belonging tomixedphagegroups or not
typeable). There was poor concordance between
phage typing and the DNA-based approaches
used, as has been observed previously [42].
Although the PVL determinant, a bicomponent
leukotoxin virulence factor linked to severe nec-
rotising fasciitis and necrotising pneumonia, has
been detected previously in the hospital setting
[43,44], it is associated more commonly with
community-acquired MRSA strains harbouring
SCCmec types IV or V [45]; it was not detected in
any of the nosocomial Hungarian isolates in the
present study. Voyich et al. [46] recently reported
that strains lacking PVL were as virulent in mouse
sepsis and abscess models as those that produce
the leukotoxin, and therefore concluded that PVL
is not the major virulence determinant of com-
munity-acquired MRSA.
In summary, the present results indicate that a
temporal recycling of the prevalent clones circu-
lating in Hungary occurred between 1994 and
2004. Although ST239-related clones are still
isolated in central Europe, e.g., in Poland [11]
and Romania [47], the prevalence of ST239-related
clones is currently almost null in Hungary.
A progressive replacement of the Hungarian
clone by the Southern German and New York ⁄ Ja-
pan epidemic clones was observed in the hospital
setting between 2001 and 2004, and the co-
dominance and massive spread of the New
York ⁄ Japan clone in a European country was
observed for the ﬁrst time.
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